ONCOHOST LTD – Trademark Portfolio

Entity Type: 99

ONCOHOST LTD holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 3 are pending. Notable registered marks include PROPHET, ONCOHOST, PROPHETNSCLC, and ONCOHOST A NEW DIMENSION TO CANCER CARE.

Hamelacha St. 3

3057319 Binyamina

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ONCOHOST LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (9 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ONCOHOST LTD have?

ONCOHOST LTD has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 pending.

What trademark classes does ONCOHOST LTD file in?

ONCOHOST LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are ONCOHOST LTD's most well-known trademarks?

ONCOHOST LTD's registered trademark portfolio includes well-known marks such as PROPHET, ONCOHOST, PROPHETNSCLC, and ONCOHOST A NEW DIMENSION TO CANCER CARE. These are among 6 currently registered trademarks in the portfolio.

What is ONCOHOST LTD's trademark registration success rate?

ONCOHOST LTD has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.